Irvine’s Urovant Sciences Ltd., which at one time was preparing to explode to almost a billion dollars in annual sales of medication to treat overactive bladders, is being folded into the U.S. operations of giant Japanese pharmaceutical firm Sumitomo Pharma Co. Ltd.